Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ligthelm

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Travel Medicine|March 10, 1999
Travel-related morbidity in travelers with insulin-dependent diabetes mellitusS O Driessen, F G Cobelens, R J Ligthelm
The Netherlands Journal of Medicine|April 1, 1991
Prolonged fever and pyuria: an uncommon manifestation of Q feverR J Ligthelm, J H Richardus, P C Stuiver, et al.
Diabetes, Obesity & Metabolism|November 10, 2009
Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose controlJ S Christiansen, A Liebl, J A Davidson, et al.
AIDS (London, England)|July 15, 1997
Sexual risk of HIV infection among expatriates posted in AIDS endemic areasR de Graaf, G van Zessen, H Houweling, et al.
Diabetes, Obesity & Metabolism|February 14, 2008
Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetesM R Clements, J Tits, B T Kinsley, et al.
Vaccine|June 29, 2005
Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled studyE M S Leyten, D Soonawala, C Schultsz, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 23, 2006
Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetesR J Ligthelm, U Mouritzen, H Lynggaard, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse eventsM M van Riemsdijk, M C J M Sturkenboom, J M Ditters, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquineM M van Riemsdijk, M C J M Sturkenboom, J M Ditters, et al.
European Journal of Clinical Pharmacology|September 21, 2002
Neuropsychiatric events during prophylactic use of mefloquine before travellingM M van Riemsdijk, J M Ditters, M C J M Sturkenboom, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Travel Medicine|March 10, 1999
Travel-related morbidity in travelers with insulin-dependent diabetes mellitusS O Driessen, F G Cobelens, R J Ligthelm
The Netherlands Journal of Medicine|April 1, 1991
Prolonged fever and pyuria: an uncommon manifestation of Q feverR J Ligthelm, J H Richardus, P C Stuiver, et al.
Diabetes, Obesity & Metabolism|November 10, 2009
Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose controlJ S Christiansen, A Liebl, J A Davidson, et al.
AIDS (London, England)|July 15, 1997
Sexual risk of HIV infection among expatriates posted in AIDS endemic areasR de Graaf, G van Zessen, H Houweling, et al.
Diabetes, Obesity & Metabolism|February 14, 2008
Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetesM R Clements, J Tits, B T Kinsley, et al.
Vaccine|June 29, 2005
Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled studyE M S Leyten, D Soonawala, C Schultsz, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 23, 2006
Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetesR J Ligthelm, U Mouritzen, H Lynggaard, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse eventsM M van Riemsdijk, M C J M Sturkenboom, J M Ditters, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquineM M van Riemsdijk, M C J M Sturkenboom, J M Ditters, et al.
European Journal of Clinical Pharmacology|September 21, 2002
Neuropsychiatric events during prophylactic use of mefloquine before travellingM M van Riemsdijk, J M Ditters, M C J M Sturkenboom, et al.
Pageof 2